Uncategorized
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Quantum Biopharma’s subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial. read more
Michael Novogratz Says Bitcoin, Ethereum Treasury Frenzy May Be Over — What Now?
The surge of companies adding cryptocurrencies to their balance sheets may be hitting a plateau, according to Galaxy Digital (NASDAQ:GLXY) CEO read more
Roku Expands Streaming Options With New Ad-Free Service At $2.99/Month
Roku shares slipped 1.48% to $84.56 as the company rolled out its $2.99 Howdy SVOD service, raised its platform revenue outlook, and marked a 63% YTD gain. read more
Weakness In Vertex Stock Seen As Buying Opportunity
Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic fibrosis drug sales. Latest Ratings for VRTX Date Firm Action From To Feb 2022 RBC Capital Downgrades Outperform Sector Perform Jan 2022 BMO Capital Upgrades Market Perform Outperform Dec 2021 Wells Fargo Initiates Coverage On Overweight View…
Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results
Latest Ratings for INSP Date Firm Action From To Feb 2022 SVB Leerink Maintains Outperform Nov 2021 Piper Sandler Maintains Overweight Nov 2021 Wells Fargo Maintains Overweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more